The novel gene EG-1 stimulates cellular proliferation

Cancer Research

Volumn 65, Issue 14, 2005, Pages 6159-6166

  Lu, Ming ^a   Zhang, Liping ^a   Maul, Raymond Scott ^a   Sartippour, Maryam R ^a   Norris, Andrew ^a   Whitelegge, Julian ^a   Rao, Jian Yu ^b   Brooks, Mai N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STIMULATION; CLONE; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIAL DERIVED GENE 1; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FAMILY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; PHOSPHOTRANSFERASES; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 22244465890     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4016     Document Type: Article

References (27)

1. Dickson RB, Lippman ME. Cancer of the breast: molecular biology of breast cancer. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven; 2000. p. 1633-51.
2. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med 2002;347:1593-603.
3. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
4. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
5. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994;86:356-61.
6. Nguyen M. Angiogenic factors as tumor markers. Invest New Drugs 1997;15:29-37.
7. Liu Y, Wang JL, Chang H, Barsky SH, Nguyen M. Breast cancer diagnosis with nipple fluid bFGF. Lancet 2000;356:567.
8. Lee MC, Tomlinson J, Nguyen M. Lessons from clinical trials of anti-angiogenic drugs in the treatment of cancer. In: Mousa SA, editor. Therapeutic implications of angiogenesis inhibitors and stimulators: Current status and future treatment directions. Texas: Landes Bioscience; 2000. p. 151-60.
9. Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003;21:60-5.
10. Nguyen M, Strubel N, Bischoff J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 1993;365:267-9.
11. Nguyen M, Corless CL, Kraling BM, et al. Vascular expression of E-selectin is increased in estrogen receptor negative breast cancer: a role for tumor cell-secreted IL-1α. Am J Path 1997;150:1307-14.
12. Diatchenko L, Lau YC, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci 1996;93:6025-30.
13. Nguyen M, Lee MC, Wang JL, et al. The human myoepithelial cell expresses a multifaceted anti-angiogenic phenotype. Oncogene 2000;19:3449-59.
14. Wang JL, Liu Y, Lee MC, et al. Identification of tumor angiogenesis-related genes by subtractive hybridization. Microvasc Res 2000;59:394-7.
15. Liu C, Shao ZM, Zhang L, et al. Human endomucin is an endothelial marker. Biochem Biophys Res Commun 2001;288:129-36.
16. Liu C, Zhang L, Beatty P, et al. Identification of a novel endothelial-derived gene. Biochem Biophys Res Commun 2002;290:602-12.
17. Zhang L, Maul RS, Rao J, et al. Expression pattern of the novel gene EG-1 in cancer. Clin Cancer Res 2004;10:3504-8.
18. Whitelegge JP, Le Coutre J, Lee JC, Prive GG, Faull KF, Kaback HR. Towards the bilayer proteome, electrospray-ionization mass spectrometery of large intact transmembrane proteins. Proc Natl Acad Sci 1999;96:10695-8.
19. Whitelegge JP, Gundersen CB, Faull KF. Electrospray-ionization mass spectrometry of intact intrinsic membrane proteins. Protein Sci 1998;7:1423-30.
20. Johnson GL, Lapadat R. Mitogen activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2.
21. Pawson T. Protein modules and signalling networks. Nature 1995;373:573-80.
22. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004;23:7906-9.
23. Ishizawar RC, Tice DA, Karaoli T, Parsons SJ. The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism. J Biol Chem 2004;279:23773-81.
24. Bromann PA, Korkaya H, Courtneidge SA. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 2004;23:7957-68.
25. Levi NL, Hanoch T Benard O, et al. Stimulation of Jim N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary α T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42. Mol Endocrinol 1998;12:815-24.
26. Gupta SK, Gallego C, Johnson GL, Heasley LE. MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts. J Biol Chem 1992;267:7987-90.
27. Daaka Y. Mitogenic action of LPA in prostate. Biochim Biophys Acta 2002;1582:265-9.